{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T03:27:24Z","timestamp":1791689244920,"version":"4.3.4"},"reference-count":46,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Therapeutic Advances in Psychopharmacology"],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:p>Clinical trials with psychedelics face several challenges that are not present to such a degree with other pharmacotherapeutics. Psychedelic therapies often include a significant therapeutic container, including preparatory and integrative psychotherapy, along with supportive intervention during dosing sessions. All these are likely to have an effect on the outcomes. Additionally, the influence of the therapeutic relationship between study subjects and study therapists is often more pronounced and more impactful on the outcomes as it is in pharmacotherapies that do not require psychotherapy. Perhaps the most important challenge with psychedelic-assisted therapy trials is the inability to effectively conceal the assignment in placebo-controlled settings. Many different approaches have been tried, however, all have suffered from a complete or significant functional unblinding making it difficult to discern the true therapeutic effect of the psychedelic in conjunction with the psychotherapeutic modalities which accompany it from a positive expectancy effect (often in the subjects receiving active intervention), which is further compounded by an additional negative expectancy effect (often in the subjects receiving placebo). This can be particularly problematic if functional unblinding is not just a nuisance variable but is deeply connected with the mechanism of therapeutic action itself. In this manuscript, we discuss various advantages and disadvantages of currently available approaches utilized in psychedelic trials and propose conceptual and methodological perspectives on approaching these problems.<\/jats:p>","DOI":"10.1177\/20451253261470523","type":"journal-article","created":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T11:06:21Z","timestamp":1784977581000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":2,"title":["Conceptual analysis of mechanisms and methods in psychedelic clinical trial design: a narrative review"],"prefix":"10.1177","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1746-7462","authenticated-orcid":false,"given":"Martin","family":"Krsak","sequence":"first","affiliation":[{"name":"Trillion Clinical and Research Customs, LLC, 5384 Uinta Street, Denver, CO, USA"},{"name":"University of Colorado School of Medicine, Aurora, CO, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Sparrow","sequence":"additional","affiliation":[{"name":"VA Boston Healthcare System, Boston, MA, USA"},{"name":"Department of Medicine, Boston University School of Medicine, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Rosner","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, MA, USA"},{"name":"Channing Division for Network Medicine, Brigham and Women\u2019s Hospital, Boston, MA, USA"},{"name":"Harvard Medical School, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"DeMolles","sequence":"additional","affiliation":[{"name":"VA Boston Healthcare System, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Shannon","sequence":"additional","affiliation":[{"name":"University of Colorado School of Medicine, Aurora, CO, USA"},{"name":"Wholeness Center, Fort Collins, CO, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,7,25]]},"reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2206443"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2020.3285"},{"key":"e_1_3_4_4_2","article-title":"Out of control: blinding, dose response, and psychosocial controls in psychedelic trials","volume":"2025","author":"Nayak SM","unstructured":"Nayak SM, Zahid Z. Out of control: blinding, dose response, and psychosocial controls in psychedelic trials. J Psychopharmacol 2025: 2698811251368367.","journal-title":"J Psychopharmacol"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-022-06221-6"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpsc.2024.02.004"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1124\/pr.118.017160"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.NAJ.0001050812.23977.85"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2023.1197281"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1021\/acsptsci.0c00194"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1038\/s44220-023-00140-x"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2019.19020172"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2019.1189"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1186\/s41073-019-0064-8"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-34938-7"},{"key":"e_1_3_4_16_2","volume-title":"Cognitive therapy and the emotional disorders","author":"Beck AT.","year":"1976","unstructured":"Beck AT. Cognitive therapy and the emotional disorders. New York: International Universities Press, 1976."},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.brat.2005.06.006"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10608-012-9476-1"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1177\/0269881119855974"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-022-06187-5"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2024.12.061"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-021-05517-w"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2022.24324"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1007\/s13142-014-0265-0"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1177\/02698811211073759"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2022.08.025"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1177\/0269881116675513"},{"key":"e_1_3_4_28_2","article-title":"Psychedelic-assisted therapy as a complex intervention: implications for clinical trial design","volume":"15","author":"Muthumaraswamy SD","year":"2025","unstructured":"Muthumaraswamy SD, Baggott MJ, Schenberg EE, et al. Psychedelic-assisted therapy as a complex intervention: implications for clinical trial design. Ther Adv Psychopharmacol 2025; 15: 20451253251381074. Erratum in: Ther Adv Psychopharmacol 2025; 15: 20451253251395232.","journal-title":"Ther Adv Psychopharmacol"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1002\/wps.20238"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2025.54843"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-025-03685-9"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0300501"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.788155"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2026.106573"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2026.0132"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.1177\/07067437231225937"},{"key":"e_1_3_4_37_2","doi-asserted-by":"publisher","DOI":"10.1002\/cpp.2945"},{"key":"e_1_3_4_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(24)00333-X"},{"key":"e_1_3_4_39_2","doi-asserted-by":"publisher","DOI":"10.1089\/psymed.2023.0020"},{"key":"e_1_3_4_40_2","doi-asserted-by":"publisher","DOI":"10.1186\/1742-7622-3-1"},{"key":"e_1_3_4_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2025.112087"},{"key":"e_1_3_4_42_2","doi-asserted-by":"publisher","DOI":"10.1101\/2025.08.13.25333530"},{"key":"e_1_3_4_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)32802-7"},{"key":"e_1_3_4_44_2","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2011.228"},{"key":"e_1_3_4_45_2","doi-asserted-by":"publisher","DOI":"10.1002\/sim.3238"},{"key":"e_1_3_4_46_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-021-01399-1"},{"key":"e_1_3_4_47_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.134.4.382"}],"container-title":["Therapeutic Advances in Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/20451253261470523","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/20451253261470523","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/20451253261470523","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T13:46:41Z","timestamp":1785246401000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/20451253261470523"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":46,"alternative-id":["10.1177\/20451253261470523"],"URL":"https:\/\/doi.org\/10.1177\/20451253261470523","relation":{},"ISSN":["2045-1253","2045-1261"],"issn-type":[{"value":"2045-1253","type":"print"},{"value":"2045-1261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7]]},"article-number":"20451253261470523"}}